What are risk factors for neuroleptic malignant syndrome?
•
2 min read
The incidence of neuroleptic malignant syndrome (NMS) has decreased significantly over the last few decades to an estimated 0.01%–0.04% of individuals on antipsychotic medications, primarily due to increased awareness and improved management. However, understanding what are risk factors for neuroleptic malignant syndrome remains critical, as this rare but potentially fatal condition can be triggered by a variety of pharmacological, patient-specific, and environmental factors.
